American College of Clinical Pharmacy
      Search      Cart
         
ACCP Report

ACCP Awards Three Meta-Analysis Training Scholarships

Last month, eight ACCP members learned about designing, conducting, and publishing meta-analyses during the course offered by the Center for Health Outcomes & PharmacoEconomic Research at the University of Arizona College of Pharmacy (the HOPE Center). ACCP partnered with the HOPE Center to make this recognized hands-on training program in meta-analysis available to ACCP members at a significantly reduced registration rate.

Each year, the course integrates in-depth instruction and action-oriented workshops to teach participants to design protocols, perform effective searches for data sets, screen studies and extract data, and conduct and interpret meta-analysis and meta-regression. The 3-day curriculum is designed for professionals and trainees with entry to intermediate levels of prior knowledge in meta-analysis. This year’s course was held June 18–20, 2018.

To further encourage members to participate in the course and publish meta-analyses pertinent to clinical pharmacy practice and research, ACCP competitively awarded three $500 scholarships to:

    Alexander Le
  • Alexander Le
    Student Pharmacist, Class of 2019
    Texas Tech University – Abilene



  • Andrew Lucas
  • Andrew Lucas, Pharm.D., M.S.
    Research Assistant Professor
    University of North Carolina Eshelman School of Pharmacy



  • Devada Singh-Franco
  • Devada Singh-Franco, Pharm.D., CDE
    Associate Professor, Pharmacy Practice
    Nova Southeastern University


In a post-course report to ACCP, one scholarship recipient noted,

The experiences and material gained by completing this training course have already begun to bear fruit and promise of future studies… I already have four meetings set up to discuss potential new meta-analyses… I am extremely excited about the acute and long-term potential of these studies and the skills [that] this training program ha[s] provided and how such studies may improve our treatment of patients in an ever-growing world of complex drug formulations and combinations of therapy.